Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment

The COVID-19 pandemic has significantly impacted the way of life worldwide and continues to bring high mortality rates to at-risk groups. Patients who develop severe COVID-19 pneumonia, often complicated with ARDS, are left with limited treatment options with no targeted therapy currently available....

Descripción completa

Detalles Bibliográficos
Autores principales: Primorac, Dragan, Čemerin, Martin, Matišić, Vid, Molnar, Vilim, Strbad, Marko, Girandon, Lenart, Zenić, Lucija, Knežević, Miomir, Minger, Stephen, Polančec, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469913/
https://www.ncbi.nlm.nih.gov/pubmed/34575557
http://dx.doi.org/10.3390/pharmaceutics13091481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469913/
https://www.ncbi.nlm.nih.gov/pubmed/34575557
http://dx.doi.org/10.3390/pharmaceutics13091481

Ejemplares similares